title: Impairment of FOS mRNA induction by a translation inhibitor puromycin in granulocytes from myelodysplastic syndrome patients.
authors.forename: Yayoi
authors.initials: Y
authors.lastname: Shikama
authors.forename: Xiaomin
authors.initials: X
authors.lastname: Feng
authors.forename: Tsutomu
authors.initials: T
authors.lastname: Shichishima
authors.forename: Tomoyuki
authors.initials: T
authors.lastname: Ono
authors.forename: Hideyoshi
authors.initials: H
authors.lastname: Noji
authors.forename: Kazuhiko
authors.initials: K
authors.lastname: Ikeda
authors.forename: Kazuei
authors.initials: K
authors.lastname: Ogawa
authors.forename: Yasuchika
authors.initials: Y
authors.lastname: Takeishi
authors.forename: Junko
authors.initials: J
authors.lastname: Kimura
mesh_terms: D016022:Case-Control Studies; D005786:Gene Expression Regulation / Q000187:drug effects; D006098:Granulocytes / Q000187:drug effects*; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000097:blood*; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology*; D016760:Proto-Oncogene Proteins c-fos / Q000096:biosynthesis*; D011691:Puromycin / Q000494:pharmacology*; D012333:RNA, Messenger / Q000235:genetics
chemical_list: D011500:Protein Synthesis Inhibitors; D016760:Proto-Oncogene Proteins c-fos; D012333:RNA, Messenger; D011691:Puromycin